Comparing Arterial Function Parameters for the Prediction of Coronary Heart Disease Events: The Multi-Ethnic Study of

Insights

Arterial stiffness, measured by C2, can predict coronary heart disease (CHD) events. Lower C2 values indicate a higher risk of future CHD, aiding in cardiovascular risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Epidemiology

Background:

  • Arterial dysfunction is linked to reduced cardiac function and increased cardiovascular disease (CVD) risk.
  • Assessing arterial properties is crucial for predicting future cardiovascular events.

Purpose of the Study:

  • To evaluate the predictive value of various arterial function measures for incident coronary heart disease (CHD) events.
  • To determine if specific arterial parameters improve cardiovascular risk prediction models.

Main Methods:

  • Utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort (baseline 2000-2002).
  • Measured arterial function using diastolic pulse contour analysis (C1, C2), carotid ultrasonography (distensibility, Young's modulus), and cardiac MRI (aortic distensibility).
  • Employed survival analysis and receiver operating characteristic (ROC) curve analysis to assess predictive capabilities.

Main Results:

  • Lower C2 values, derived from pulse contour analysis, were significantly associated with a higher risk of future CHD events (HR 0.73 per SD increment, P < 0.001).
  • C2 provided statistically significant additional discrimination for CHD prediction beyond standard risk factors (AUC 0.743 vs. 0.736, P = 0.04).
  • Other measures like C1, carotid distensibility, Young's modulus, and aortic distensibility showed non-significant associations with CHD events after adjustment.

Conclusions:

  • Diastolic pulse contour analysis parameter C2 is a valuable, independent predictor of incident coronary heart disease.
  • Integrating C2 into risk models may enhance the identification of individuals at higher risk for cardiovascular events.
  • Further research can explore the clinical utility of C2 in routine cardiovascular risk assessment.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
677
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
790
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
569
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
860
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
681